作者:Jeffrey T. Bagdanoff、Rama Jain、Wooseok Han、Shejin Zhu、Ann-Marie Madiera、Patrick S. Lee、Xiaolei Ma、Daniel Poon                                    
                                    
                                        DOI:10.1016/j.bmcl.2015.07.091
                                    
                                    
                                        日期:2015.9
                                    
                                    A series of structure based drug design hypotheses and focused screening efforts led to the identification of tetrahydropyrrolo-diazepenones with striking potency against ERK2 kinase. The role of fluorination in mitigating microsomal clearance was systematically explored. Ultimately, it was found that fluorination of a cyclopentanol substructure provided significant improvement in both potency and human metabolic stability. (C) 2015 Elsevier Ltd. All rights reserved.